Indo-Bangla Pharmaceuticals (DHA:IBP) Asset Turnover: 0.00 (As of . 20)


DHA:IBP Indo-Bangla Pharmaceuticals Ltd DHA:IBP
32 GF Score
Price BDT15.30
View Full Analysis

What is Indo-Bangla Pharmaceuticals Asset Turnover?

Indo-Bangla Pharmaceuticals DHA:IBP +1.32% 32 Asset Turnover is 0.00 as of . 20. GuruFocus rates DHA:IBP with a GF Score™ of 32/100.

Asset Turnover measures how quickly a company turns over its asset through sales. It is calculated as Revenue divided by Total Assets. Indo-Bangla Pharmaceuticals's Revenue for the six months ended in . 20 was BDT Mil. Indo-Bangla Pharmaceuticals's Total Assets for the quarter that ended in . 20 was BDT Mil. Therefore, Indo-Bangla Pharmaceuticals's Asset Turnover for the quarter that ended in . 20 was 0.00.

Asset Turnover is linked to ROE % through Du Pont Formula. Indo-Bangla Pharmaceuticals's annualized ROE % for the quarter that ended in . 20 was %. It is also linked to ROA % through Du Pont Formula. Indo-Bangla Pharmaceuticals's annualized ROA % for the quarter that ended in . 20 was %.

Indo-Bangla Pharmaceuticals  (DHA:IBP) Asset Turnover Explanation

Asset Turnover is linked to ROE % through Du Pont Formula.

Indo-Bangla Pharmaceuticals's annulized ROE % for the quarter that ended in . 20 is

ROE %**(Q: . 20 )
=Net Income/Total Stockholders Equity
=/
=(Net Income / Revenue)*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=( / )*( / )*(/ )
=Net Margin %*Asset Turnover*Equity Multiplier
= %**
=ROA %*Equity Multiplier
= %*
= %

Note: The Net Income data used here is two times the semi-annual (. 20) net income data. The Revenue data used here is two times the semi-annual (. 20) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** The ROE % used above is for Du Pont Analysis only. It is different from the defined ROE % page on our website, as here it uses Net Income instead of Net Income attributable to Common Stockholders in the calculation.

It is also linked to ROA % through Du Pont Formula:

Indo-Bangla Pharmaceuticals's annulized ROA % for the quarter that ended in . 20 is

ROA %(Q: . 20 )
=Net Income/Total Assets
=/
=(Net Income / Revenue)*(Revenue / Total Assets)
=( / )*( / )
=Net Margin %*Asset Turnover
= %*
= %

Note: The Net Income data used here is two times the semi-annual (. 20) net income data. The Revenue data used here is two times the semi-annual (. 20) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Be Aware

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Therefore, it is a good sign if a company's Asset Turnover is consistent or even increases. If a company's asset grows faster than sales, its Asset Turnover will decline, which can be a warning sign.

Indo-Bangla Pharmaceuticals Asset Turnover Related Terms

Indo-Bangla Pharmaceuticals Asset Turnover Historical Data

* Premium members only.

The historical data trend for Indo-Bangla Pharmaceuticals's Asset Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Indo-Bangla Pharmaceuticals Asset Turnover Chart

Indo-Bangla Pharmaceuticals Annual Data
Trend
Asset Turnover

Indo-Bangla Pharmaceuticals Semi-Annual Data
Asset Turnover

DHA:IBP vs : Asset Turnover Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Indo-Bangla Pharmaceuticals's Asset Turnover, along with its competitors' market caps and Asset Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Indo-Bangla Pharmaceuticals Asset Turnover vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Indo-Bangla Pharmaceuticals's Asset Turnover distribution charts can be found below:

* The bar in red indicates where Indo-Bangla Pharmaceuticals's Asset Turnover falls into.


DHA:IBP
32GF Score
Indo-Bangla Pharmaceuticals Ltd DHA:IBP
Asset Turnover is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Indo-Bangla Pharmaceuticals Asset Turnover Calculation

Asset Turnover measures how quickly a company turns over its asset through sales.

Indo-Bangla Pharmaceuticals's Asset Turnover for the fiscal year that ended in . 20 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (A: . 20 )/( (Total Assets (A: . 20 )+Total Assets (A: . 20 ))/ count )
=/( (+)/ )
=/
=

Indo-Bangla Pharmaceuticals's Asset Turnover for the quarter that ended in . 20 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (Q: . 20 )/( (Total Assets (Q: . 20 )+Total Assets (Q: . 20 ))/ count )
=/( (+)/ )
=/
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies with low profit margins tend to have high Asset Turnover, while those with high profit margins have low Asset Turnover. Companies in the retail industry tend to have a very high turnover ratio.

Frequently Asked Questions Learn more about Asset Turnover →
What does a Asset Turnover of 0.00 mean?
Indo-Bangla Pharmaceuticals (DHA:IBP) has a Asset Turnover of 0.00 as of . 20. Asset turnover equals current-period sales over average total assets over the past two periods. View historical data on Indo-Bangla Pharmaceuticals and its competitors.
Is Indo-Bangla Pharmaceuticals' Asset Turnover too high?
Indo-Bangla Pharmaceuticals' current Asset Turnover is 0.00. Overall, Indo-Bangla Pharmaceuticals has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Indo-Bangla Pharmaceuticals' Asset Turnover compare to ?
Indo-Bangla Pharmaceuticals' Asset Turnover of 0.00 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Asset Turnover for a Drug Manufacturers company?
A good Asset Turnover depends on the Drug Manufacturers industry context. However, Asset Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Asset Turnover mean?
A high Asset Turnover can signal that a stock is expensive relative to its fundamentals. Asset turnover equals current-period sales over average total assets over the past two periods. View historical data on Indo-Bangla Pharmaceuticals and its competitors. Indo-Bangla Pharmaceuticals's current Asset Turnover is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Indo-Bangla Pharmaceuticals stock overvalued right now?
Indo-Bangla Pharmaceuticals (DHA:IBP) has a current Asset Turnover of 0.00. The current Asset Turnover is 0.00. Indo-Bangla Pharmaceuticals' overall GF Score™ is 32/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Asset Turnover calculated?
Asset Turnover is calculated from a company's financial statements. For Indo-Bangla Pharmaceuticals (DHA:IBP), the current Asset Turnover is 0.00 as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Indo-Bangla Pharmaceuticals Business Description

Comparable Companies
Address Ahmed Akbar Sobhan Road, Block B, Plot No. 183, 6th Floor, Bashundhara R/A, Baridhara, Dhaka, BGD, 1229
Indo-Bangla Pharmaceuticals Ltd is engaged in the manufacturing, marketing, and distribution of generic pharmaceutical products. The products of the company include human drugs dosages form such as tablets, capsules, syrup, oral saline, and suspension. The products of the company are sold in the domestic market.
32GF Score

Get the complete analysis for DHA:IBP

Asset Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

BDT15.30
Price